Navigation Links
FBR Capital Markets Hires Senior Healthcare Analyst
Date:11/2/2007

Christopher Warren to Cover Medical Devices

ARLINGTON, Va., Nov. 2 /PRNewswire-FirstCall/ -- FBR Capital Markets Corporation (Nasdaq: FBCM) (FBR Capital Markets) today announced that Christopher Warren has joined FBR Capital Markets as a Senior Vice President and Senior Research Analyst within its healthcare group and will focus on the medical device sector.

"Chris has nearly ten years of experience in equity research, and we value the disciplined, rigorous method he's developed as an analyst over that period," said David Khani, Director of Research. "We continue to expand our team of analysts, and the addition of coverage for medical device equities will complement the expertise of our healthcare group. FBR Capital Markets Research has been investing in its growth and value products and continues to expand these platforms."

Before joining FBR Capital Markets, Mr. Warren was a senior medical device analyst with SunTrust Robinson Humphrey. Prior to that, he was a senior medical device analyst with Janney Montgomery Scott. Mr. Warren began his career as an investment banking analyst at Credit Suisse First Boston.

Mr. Warren will be based in FBR Capital Markets' New York Office.

FBR Capital Markets Corporation (FBR Capital Markets), a majority-owned subsidiary of Friedman, Billings, Ramsey Group, Inc. (FBR), provides investment banking*, merger and acquisition advisory services*, institutional brokerage*, asset management and private wealth services. FBR Capital Markets focuses capital and financial expertise on eight industry sectors: consumer, diversified industrials, energy & natural resources, financial institutions, healthcare, insurance, real estate, and technology, media & telecom. FBR is headquartered in the Washington, D.C. metropolitan area with offices in Arlington, VA; Boston; Dallas; Houston; Irvine; London, England; New York; San Francisco; and Sydney, Australia. For more information, please visit http://www.fbrcapitalmarkets.com.

*Friedman, Billings, Ramsey & Co., Inc.


'/>"/>
SOURCE FBR Capital Markets Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Gay capital reeling with rising HIV infection
2. Drugs Manufacturers Capitalizing On The Surge In Demand For Bone Health Care
3. Meningitis is rocking the capital again
4. India Crowned As the Diabetic Capital
5. China Crowned the Diabetic Capital of the World
6. Low Awareness Of Kawasaki Disease In Capital: Parents Form Support Group
7. Zagreb, capital of Croatia, affected by first bird flu case
8. Chikungunya in the Capital
9. Dengue Outbreak in the Capital is not an Epidemic: Government
10. Private Health Clinics in the Capital on Strike
11. Migration is the Cause for Fresh Polio Cases in the Capital: Sheila Dikshit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon ... industry standards and specifications such as ANSI, ISO and proven test methods used ...
(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis ... type of groin injury, it occurs when the muscles around the pelvis become ... and around the lower torso, as well as accompanying tenderness and weakness. Without ...
(Date:3/27/2017)... ... 2017 , ... EpiGentek , a Farmingdale, NY-based biotech ... methylation “gold rush” with their established portfolio of optimized assay kits that measure ... m6A , RNA methylation has received a new burst in interest as ...
(Date:3/27/2017)... ... , ... Janet Schloz is still in shock after receiving a $2,500 Academic Award from ... time,” she said. , She thinks the coming week is going to be a very ... have to help my students.” , The award will allow the 4th grade teacher at ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is consistently ... and require expert user knowledge. In a live webinar on April 11th and ... yet highly accurate, determination of sodium. , It has long been known that ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... BOSTON , March 27, 2017 /PRNewswire/ ... company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a ... of innovative therapies based upon tetracycline chemistry, announced ... for the treatment of moderate to severe acne ... is a once-daily, oral, narrow spectrum tetracycline-derived antibiotic ...
(Date:3/27/2017)... -- Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that its Board ... as Impax,s President and Chief Executive Officer and a ... Mr. Bisaro will succeed J. Kevin Buchi , ... Officer since December of 2016. With ... Bisaro, 56, is an accomplished global business leader who ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. ... for life-threatening inherited liver diseases in children, today ... full year ended December 31, 2016 and provided ... "PhaseRx continued to make progress during the ... positive results from our non-human primate safety study, and ...
Breaking Medicine Technology: